Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma

NCT00338377 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

1230

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

BIOLOGICAL: Dendritic Cell Immunization
DRUG: Cyclophosphamide
DRUG: Fludarabine
BIOLOGICAL: T-Cells
BIOLOGICAL: Interleukin-2
DRUG: Mesna
BIOLOGICAL: Intrathecal T-Cells
BIOLOGICAL: Intrathecal Interleukin-2

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]